Tag Archive for LifeVantage

LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

Salt Lake City, Utah – LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the “Board”), has decided to retire in April 2026.
Fife will continue in his role as President and Chief Executive Officer during the transition period to ensure business continuity through his retirement date. The Board is conducting an extensive executive search and anticipates announcing the new CEO in the coming months.

“To ensure continuity and position LifeVantage for continued success, the Board has been carrying out comprehensive succession planning for Steve’s eventual retirement,”

said Raymond Greer, Chairman of the Board of LifeVantage.

“This well-planned transition ensures continuity and positions LifeVantage for continued success. Steve has been an exceptional leader whose strategic insights and focus on operational excellence have been pivotal in transforming the Company’s business and driving growth across multiple dimensions. His commitment to our consultants, customers, employees and shareholders has created a strong foundation for future growth. While we will miss his leadership, we respect his decision to retire and are grateful for his many contributions to LifeVantage.”
“Leading LifeVantage has been one of the

Read more...

LifeVantage Reports Financial Results for Q2 of 2026

 
Salt Lake City, Utah – LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, recently announced financial results for its second fiscal quarter ended December 31, 2025.
Second Quarter Fiscal 2026 Summary*:

Revenue was $48.9 million, a decrease of 27.8% from the prior year period. Revenue was up 2.9% sequentially from the first quarter.

Revenue in the Americas decreased 32.6%, and revenue in Asia/Pacific & Europe decreased 2.1%.

Net income per diluted share was $0.02, versus $0.19 per diluted share a year ago;

Adjusted earnings per diluted share was $0.15, compared to $0.22 a year ago; and

Adjusted EBITDA was $3.9 million compared to $6.5 million a year ago.

* All comparisons are on a year over year basis and compare the second quarter of fiscal 2026 to the second quarter of fiscal 2025, unless otherwise noted.
Steve Fife, President and CEO of LifeVantage said:
“The second quarter reflected challenging competitive dynamics in the weight loss market as we cycled the launch of our MindBody GLP-1 System™ in October 2024.
We acknowledge that our performance during the quarter did not meet your expectations or ours and we are redoubling our efforts to stabilize our GLP-1 business and make the other changes necessary to return to

Read more...

LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showcasing Innovation and Integration

The company shared momentum following the LoveBiome integration and unveiled its Daily Activation App
Salt Lake City, Utah – LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, announced the successful conclusion of its Global Kickoff, a virtual company-wide event that united LifeVantage Consultants worldwide and set the tone for a new year of growth, innovation, and momentum.
Breakthrough was unveiled as the theme of the year—representing a shared commitment to moving beyond perceived limits. For Consultants, Breakthrough means unlocking new levels of leadership, impact, and business growth; for consumers, it reflects LifeVantage’s ongoing pursuit of scientific innovation that helps individuals experience meaningful advances in their health and wellness.
The Global Kickoff highlighted progress following the integration of LoveBiome, as well as the strength of LifeVantage’s expanded global sales force. With shared science, products, and purpose, the combined organization entered 2026 aligned around a unified vision, reinforced through global programming and follow-up regional activations in key markets.
A key announcement was the launch of Daily Activation, a new LifeVantage mobile app available to both Consultants and for the first time, customers. Introduced alongside the company’s new Activate90 Challenge, the app provides a centralized experience for tracking product usage, activation accelerators, and

Read more...

LifeVantage Appoints Mike Edwards as Chief Technology Officer

LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation.
Salt Lake City, Utah – LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the addition of Mike Edwards as Chief Technology Officer.
Edwards brings more than 25 years of experience as an accomplished senior executive specializing in technology leadership and enterprise transformation.

“Mike is a strategic leader with a strong track record of translating technological innovation into measurable business impact and we are delighted to have him join the LifeVantage team,”

said Steve Fife, President and CEO of LifeVantage.

“His expertise in eCommerce, AI, CRM systems, and mobile technology will be instrumental in accelerating our digital transformation and delivering next-generation technology solutions for our independent Consultants and customers as we continue advancing our growth strategy. Mike’s proven ability to scale technology infrastructure will be critical as we expand our global footprint.”

Most recently, Edwards served as Chief Technology Officer at a direct selling company where he led comprehensive enterprise-wide transformation initiatives across eCommerce platforms, artificial intelligence implementation, customer relationship management systems, back-office operations, mobile applications, and customer experience enhancement.
His technology leadership has modernized legacy systems, scaled global eCommerce infrastructure,

Read more...

New Study: LifeVantage P84 Positively Impacts Gut Health, Peptide Production

New in vitro research shows P84 influences key gut peptides – including one by more than 1,000% – supporting cellular pathways tied to regulation, repair, and restoration
LifeVantage® Corporation (Nasdaq:LFVN) , a leading health and wellness company with products designed to activate optimal health processes at the cellular level, recently announced new in vitro study results for its proprietary P84 formula revealing strong biological activity in cellular pathways linked to gut regulation, repair, and restoration.*
In the controlled, third-party study, targeted gene expression and protein concentration were measured using four gut cell types. Fourteen gut peptides and proteins known to regulate, repair, and restore the gut including CCK, NTS, EREG, GRP, OXM, CDH1, TFF3, Zonulin, CLDN1, OCLN, MUC2, GLP-2, VIP and SST were thoroughly examined.
All 14 peptides were influenced in the desired direction, with key results including: *†††

GRP (gastrin-releasing peptide responsible for sending alerts to fire up digestion): +1,087% increase*†††
TFF3 (trefoil factor 3 which manages gut lining repair): +116% increase*†††
VIP (vasoactive intestinal peptide which helps to calm overactive areas of the gut): +100% increase*†††
OXM (oxyntomodulin which coordinates nutrient absorption): +77% increase*†††
CCK (cholecystokinin which ensures fats and proteins are properly processed): +69% increase*†††

“These findings demonstrate that our proprietary P84 blend has a remarkable

Read more...

LifeVantage Empowers Consultants to “Love Life & Drive” at Momentum Academy 2025

Dallas event delivers new products, tools, and business strategies designed to accelerate performance and leadership
LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of Momentum Academy 2025, a dynamic, high-impact event that brought together thousands of Consultants from across the U.S. from October 23-25 at the Hilton Anatole in Dallas, TX.
This year’s event centered around the theme: “Love Life & Drive” – inspiring Consultants to take the driver’s seat in their businesses with purpose, speed, and unstoppable momentum. It also represents the first time Consultants from LoveBiome, who began integrating with LifeVantage on October 1, 2025, were together with LifeVantage Consultants at a large in-person event. The event served to increase engagement and alignment of the two companies across markets, products, culture, and leadership.
The purpose of the event was for Consultants to hear about opportunities to accelerate their business and ignite their leadership potential through targeted workshops, in-depth seminars, and dynamic keynotes focused on enrollment, retention, and advancement strategies.
Watch the event recap video here

Attendees also were trained on Healthy Edge — a groundbreaking combination that pairs the original, proven technology of Protandim® Nrf2 Synergizer with the emerging science of LoveBiome P84. Individually, each product delivers powerful benefits

Read more...

LifeVantage Announces Closing of LoveBiome Acquisition

Strategic acquisition strengthens leadership position in direct sales and gut and microbiome health market
LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the closing of its previously announced acquisition of LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions. Under the terms of the completed transaction, LifeVantage has acquired LoveBiome’s critical operating assets essential to the microbiome health business, including the retention of key LoveBiome personnel.

“We are pleased to have closed the LoveBiome acquisition and look forward to working with Kelly Olsen and the LoveBiome team to accelerate growth by leveraging their innovative microbiome solutions with our proven Activation technologies as one LifeVantage,”

said Steve Fife, President and CEO of LifeVantage.

“This strategic transaction expands our product portfolio into the rapidly growing gut health market while also broadening our reach in key markets including the US, Taiwan, and Europe, underscoring our deep commitment to our mission of offering people around the world a better path to wellness through Activation.”
“We are excited to be part of LifeVantage and believe the partnership will allow us to achieve our aggressive growth plans,”

explained Kelly Olsen, founder and CEO of LoveBiome.

“By combining our innovative P84 product with LifeVantage’s proven

Read more...

LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness

Strategic acquisition expands network of Consultants, and strengthens LifeVantage’s Activation differentiation in the rapidly growing gut health market
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, recently announced it has entered into a definitive agreement to acquire LoveBiome, a pioneering direct sales company dedicated to comprehensive microbiome care and wellness solutions.*
LoveBiome has established itself as a leader in the emerging microbiome health sector, focusing on the critical connection between gut health and overall wellness. The company’s innovative P84 product takes the guesswork out of gut health, regulating, repairing, and restoring the gut and microbiome through Activation, recognizing that comprehensive gut health is fundamental to health across multiple body systems.
The acquisition aligns perfectly with LifeVantage‘s differentiation of activating optimal health processes throughout the body, helping your body make the things it needs for health including antioxidants and collagen. LoveBiome’s expertise in microbiome science complements LifeVantage’s existing portfolio of scientifically validated activators, including the flagship Protandim® family of products and the MindBody GLP-1 System™.*

“This strategic acquisition represents an acceleration of our mission to offer people around the world a better path to wellness and a healthy vibrant life while also serving as a natural

Read more...

LifeVantage Announces Expanded Clinical Study for MindBody GLP-1 System™

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced new results from its second human clinical study on the MindBody GLP-1 System™, revealing even more compelling outcomes across a broader participant base.
When researchers combined data from the most recent clinical trial completed in April 2025, with findings from the initial trial conducted in fall 2024, the average increase of GLP-1 improved to over 200% – a significant rise from the previously reported 140%. GLP-1 is a critical hormone that supports appetite regulation, metabolic health, and fat processing. This enhanced result further reinforces the effectiveness of the MindBody GLP-1 System in promoting sustainable, natural wellness through Activation.*‡‡

“These findings validate the effectiveness of our natural approach to stimulating the body’s own production of GLP-1 and other key metabolic hormones,”

said Lisa Barnes, Vice President of R&D and Regulatory at LifeVantage.

“The MindBody GLP-1 System and living an activated lifestyle produces meaningful, lasting results – helping people manage cravings, improve self-control, and support sustainable metabolic health naturally. We remain committed to delivering evidence-based innovations that empower health from within.*”

Key findings from LifeVantage’s U.S. clinical studies on the MindBody GLP-1 System include:

Over 200% average increase in GLP-1

Read more...

LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign, Incentives to Drive Global Growth

LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, held its global Activate 2025 virtual event on Saturday, July 12. The event, supported by Consultant-hosted watch parties and local in-person gatherings, provided a dynamic platform to inspire Consultant business engagement and growth. Activate 2025 also celebrated innovation, reinforcing LifeVantage’s ongoing commitment to evolving the direct selling model in today’s fast-paced market.
LifeVantage introduced its bold “Summer in the Fast Lane” campaign during the event, building on the Company’s “Drive” message launched in January to encourage Consultants to tap into their internal motivations and take proactive control of their success. Designed to reward consistent business performance, “Summer in the Fast Lane” offers multiple ways for Consultants at every rank to qualify for new sales incentives, including exclusive mini trips worldwide, while fostering engagement and reach on social channels.
Another component of “Summer is the Fast Lane” is the new High Speed Health Stack, which features MindBody GLP-1 System™, Protandim® Nrf2 Synergizer®, PhysIQ™ Fat Burn, and for the first time ever – a free Protandim® NAD Synergizer®. Together, the powerful stack offers a synergistic approach to weight management, metabolic activation, and long-term wellness.*
“Summer

Read more...